BlackRock BSTZ director Mahoney reports no holdings

Director Francis C. Mahoney filed an initial ownership report for BSTZ showing no reported holdings or transactions.

Available on EDGAR 09/17/2026 - 05:16 PM EDT Accepted by SEC EDGAR 09/17/2026 - 05:15 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

BlackRock Science & Technology Term Trust (BSTZ) filed an initial statement of beneficial ownership for director Francis C. Mahoney. The filing reports no equity or derivative holdings and no transactions in the trust’s securities at the time of this initial report.

Key Figures

Reported purchase transactions: 0 transactions Reported sale transactions: 0 transactions Reported derivative transactions: 0 transactions +1 more

4 metrics

Reported purchase transactions 0 transactions Initial Form 3 for director Francis C. Mahoney

Reported sale transactions 0 transactions Initial Form 3 for director Francis C. Mahoney

Reported derivative transactions 0 transactions Initial Form 3 for director Francis C. Mahoney

Reported holdings entries 0 holdings Initial Form 3 for director Francis C. Mahoney

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 3 filing for BSTZ disclose about Francis C. Mahoney?

The Form 3 for BSTZ shows that director Francis C. Mahoney filed an initial statement of beneficial ownership and reported no transactions and no holdings in the trust’s securities as of the filing’s reporting date.

Does Francis C. Mahoney hold any BSTZ shares according to this Form 3?

According to this Form 3, no holdings in BlackRock Science & Technology Term Trust are reported for director Francis C. Mahoney. The filing lists no equity positions and no derivative positions at the time of the report.

Were any BSTZ transactions reported in Francis C. Mahoney’s Form 3?

No. The Form 3 reports no transactions in BSTZ securities for director Francis C. Mahoney. The transaction counts for purchases, sales, exercises, gifts, and restructurings are all shown as zero.

What is Francis C. Mahoney’s role at BlackRock Science & Technology Term Trust (BSTZ)?

The filing identifies Francis C. Mahoney as a director of BlackRock Science & Technology Term Trust. He is not reported as an officer or a ten percent owner in this document.

Does the BSTZ Form 3 mention any Rule 10b5-1 trading plan for Francis C. Mahoney?

No Rule 10b5-1 trading plan is reported for Francis C. Mahoney in this Form 3. The filing does not attribute any transactions to a pre-arranged trading plan because no transactions are disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Mahoney Francis C.

(Last) (First) (Middle)

50 HUDSON YARDS

(Street)

NEW YORK NEW YORK 10001

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
09/08/2026

3. Issuer Name and Ticker or Trading Symbol
BlackRock Science & Technology Term Trust [ BSTZ ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Gladys Chang as Attorney-in-Fact	09/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)